Siljansvik has received a clear short-term catalyst as Rättvik Municipality, already a major shareho...
Berner Industrier has today signed an agreement to acquire the Norwegian company Typhonix, thereby s...
Redeye is positive about the regulatory approval in Japan for the next-generation TetraGraph system ...
Redeye comments on the topline data from the phase III study of imlifidase in anti-GBM disease.
Redeye has updated its estimates and valuation for Truecaller following continued pressure on advert...
Redeye comments on Avensia’s November sales figures.
Gofore just announced it is joining forces with an AI-focused niche company, founded by key employee...
Aktia’s Q3 showed that frequent changes during 2025 did not have a visible impact on the bank; on th...
On 11 December 2025, Hella announced its first series production order for High-Resolution Radar (HR...
The announcement of Nanexa’s first licensing deal marks a meaningful validation of the PharmaShell p...
* Careium states that it will not meet FY'25 outlook.
Redeye comments on Optomed’s directed share issue, raising EUR6.
I väntans tider med rekordkvartal i ryggen för Railcare: Nya uppdrag bör rulla in under vintern för ...
Redeye resumes coverage and updates its view on Gapwaves following the Q3 report and the completion ...
Systemair levererar sitt starkaste kvartal hittills med högre försäljning än väntat, stigande margin...
